Interaction Between Patient and Healthcare Provider: Response to Acupuncture in Knee Osteoarthritis

November 15, 2013 updated by: M.D. Anderson Cancer Center

The Impact of Patient-Provider Interaction on Response to Acupuncture

Interactions between patients and healthcare providers may have a significant impact on a patient's response to therapy. In this study, patients with osteoarthritis (OA) of the knee will receive either acupuncture or sham acupuncture. The acupuncturists will be trained to interact with the patients in specific ways. The study will evaluate those interactions.

Study Overview

Detailed Description

This study will examine placebo responses in the context of practitioner-patient interactions at the time of the encounter. Phase 1 of this study identified patient-related determinants of placebo response, such as beliefs and expectations toward treatment of knee OA with acupuncture. Phase 2 of the study evaluated an assessment tool to measure these determinants. Phase 3 of the study is a randomized controlled trial to evaluate whether placebo effects in patients with knee OA can be enhanced by the acupuncturists' communicative style, which can affect a patient's cognitive expectancies and beliefs.

Patients will initially be randomized to one of two groups, each with a different model for practitioner-patient interaction. Acupuncture practitioners will be trained to follow semi-structured communicative styles, including traditional approaches in Chinese medicine and techniques previously described in patient-doctor communications studies. Within each of these groups, patients will be further randomized to receive either acupuncture or sham acupuncture. Patients will have 6 weeks of biweekly treatment visits. Patients will be followed for 6 months. Visits will be weekly during the first 6 weeks of the study and monthly thereafter.

The study will also include a natural cohort group composed of patients on a study waiting list; these patients will be offered acupuncture 3 months after study entry.

Study Type

Interventional

Enrollment (Actual)

639

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • Baylor College of Medicine
      • Houston, Texas, United States, 77030
        • University of Texas M. D. Anderson Cancer Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • OA diagnosis according to the American College of Rheumatology criteria
  • Pain in the knee of at least 3 or more on a 0 to 10 scale (0 none, 10 extreme pain) within 2 weeks prior to study entry
  • Stable treatment with anti-inflammatory and analgesic medications during the month prior to study entry
  • If receiving glucosamine, stable dosage for 2 months prior to study entry
  • Adequate cognitive status as determined by the study officials
  • Living in the community
  • Ability to communicate in English without a translator
  • Access to a telephone

Exclusion Criteria:

  • Other diagnosed joint diseases, such as rheumatoid arthritis
  • Previous treatment with acupuncture (for any condition)
  • Intra-articular injections in the knee in the 2 months prior to study entry

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm 1: Acupuncture
Participants will receive acupuncture
Electroacupuncture treatments provided two times per week for 6 weeks
Other Names:
  • Electroacupuncture
  • TENS
Placebo Comparator: Arm 2: Shallow needling
Participants will receive shallow needling on non-mederian points
Placebo acupuncture treatments provided 2 times per week for 6 weeks
Other Names:
  • Sham acupuncture
Other: Arm 3: No Acupuncture or Placebo Treatment
Participants will receive usual care, no acupuncture or placebo acupuncture treatment.
Usual care for knee osteoarthritis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale
Time Frame: 3-month
3-month
Joint-Specific Multidimensional Assessment of Pain (J-MAP) to evaluate placebo effects on the different dimensions of pain
Time Frame: 3-month
3-month
Patient satisfaction with their knee condition (SKIP)
Time Frame: 3-month
3-month

Secondary Outcome Measures

Outcome Measure
Time Frame
SF-12
Time Frame: 3-month
3-month
Range of motion of each knee
Time Frame: 3-month
3-month
Timed walking test
Time Frame: 3-month
3-month
Locus of control
Time Frame: Baseline
Baseline
Optimism
Time Frame: 3-month
3-month
Self-efficacy
Time Frame: baseline
baseline
Cognitive pain
Time Frame: 3-month
3-month
Anxiety
Time Frame: 3-month
3-month
Social support
Time Frame: 3-month
3-month
Patient reaction
Time Frame: 3-month
3-month
Physician trust
Time Frame: 3-month
3-month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria E. Suarez-Almazor, MD, PhD, M.D. Anderson Cancer Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2002

Primary Completion (Actual)

July 1, 2006

Study Completion (Actual)

August 1, 2006

Study Registration Dates

First Submitted

April 23, 2003

First Submitted That Met QC Criteria

April 23, 2003

First Posted (Estimate)

April 24, 2003

Study Record Updates

Last Update Posted (Estimate)

November 18, 2013

Last Update Submitted That Met QC Criteria

November 15, 2013

Last Verified

November 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • R01AR049999 (U.S. NIH Grant/Contract)
  • NIAMS-087 (Other Identifier: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS))
  • 2006-0605 (Other Identifier: UT MDACC Study ID)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis

Clinical Trials on Acupuncture

Subscribe